Cargando…

Target Groups for a Short Dexamethasone Course among Critically Ill COVID-19 Patients

INTRODUCTION: Corticosteroids are one of the most promising therapeutic agents for critically ill patients with coronavirus disease 2019 (COVID-19). Despite emerging data, assessed populations and regimens vary, and there are patient subgroups whose response to steroids remains unclear. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oganesyan, Armen, Menzulin, Ruslan, Surovoy, Yury, Nikiforchin, Andrei, Zykov, Kirill
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645403/ https://www.ncbi.nlm.nih.gov/pubmed/34877019 http://dx.doi.org/10.1155/2021/5557302

Ejemplares similares

Tigecycline Immunodetection Using Developed Group-Specific and Selective Antibodies for Drug Monitoring Purposes
por: Galvidis, Inna A., et al.
Publicado: (2023)

Dexamethasone: A boon for critically ill COVID-19 patients?
por: Patel, Shailesh Kumar, et al.
Publicado: (2020)

Short term survival of critically ill COVID-19 Egyptian patients on assisted ventilation treated by either Dexamethasone or Tocilizumab
por: Rashad, Alaa, et al.
Publicado: (2021)

Impact of Dexamethasone on the Pathogen Profile of Critically Ill COVID-19 Patients
por: Kodde, Cathrin, et al.
Publicado: (2023)

The clinical course of acute quadruplegia of the critically ill
por: Maňák, J, et al.
Publicado: (2001)

Assessment and clinical course of hypocalcemia in critical illness
por: Steele, Tom, et al.
Publicado: (2013)

Recurrence of Gram-negative nosocomial pneumonia in the critically ill patient following short-course antibiotic therapy
por: Pugh, Richard, et al.
Publicado: (2007)

Is fixed short-course antimicrobial therapy justified for patients who are critically ill with intra-abdominal infections?
por: Takesue, Yoshio, et al.
Publicado: (2019)

Hyperammonemic Encephalopathy and Lipid Dysmetabolism in a Critically Ill Patient After a Short Course of Amiodarone
por: Cappe, Maximilien, et al.
Publicado: (2019)

The utility of CRP with the use of dexamethasone and Tocilizumab in critically ill patients with COVID-19
por: Zacharias, Harry, et al.
Publicado: (2022)

Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
por: Camou, Fabrice, et al.
Publicado: (2022)

Dexamethasone Modulates the Cytokine Response but Not COVID-19-Induced Coagulopathy in Critically Ill
por: Dechamps, Mélanie, et al.
Publicado: (2023)

Time course and clinical relevance of thrombocytopenia in critical illness
por: Venugopal, N, et al.
Publicado: (2015)

Soft-Tissue Myoepithelioma of the Retroperitoneal Space Mimicking a Pancreatic Tumor: A Case Report and Literature Review
por: Nikiforchin, Andrei, et al.
Publicado: (2020)

A Rare Case of Metastatic Heterogeneous Poorly Differentiated Neuroendocrine Carcinoma of Ileum: A Case Report and Literature Review
por: Nikiforchin, Andrei, et al.
Publicado: (2020)

A Rare Case of Invasive Mucormycosis in a Diabetic Patient Treated with a Short Course of Dexamethasone
por: Randhawa, Gurchetan, et al.
Publicado: (2021)

Risk factors in critical illness myopathy during the early course of critical illness: a prospective observational study
por: Weber-Carstens, Steffen, et al.
Publicado: (2010)

Prognostic Implication of Adrenocortical Response during the Course of Critical Illness
por: Song, Jin Hwa, et al.
Publicado: (2019)

Understanding the Course of Critical Illness Through a Lifeworld Approach
por: Flinterud, Stine Irene, et al.
Publicado: (2021)

Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients
por: Rothe, Kathrin, et al.
Publicado: (2021)

Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
por: Kevorkian, Jean-Philippe, et al.
Publicado: (2021)

Approaches to drug therapy for COPD in Russia: a proposed therapeutic algorithm
por: Zykov, Kirill A, et al.
Publicado: (2017)

WHO WELCOMES PRELIMINARY RESULTS ABOUT DEXAMETHASONE USE IN TREATING CRITICALLY ILL COVID -19 PATIENTS
Publicado: (2020)

Endothelial, Immunothrombotic, and Inflammatory Biomarkers in the Risk of Mortality in Critically Ill COVID-19 Patients: The Role of Dexamethasone
por: Keskinidou, Chrysi, et al.
Publicado: (2021)

Critically ill patients with cancer and sepsis: clinical course and prognostic factors
por: Rabello, LSCF, et al.
Publicado: (2011)

Targeted continuous EEG monitoring in critically ill patients: The long and the short of a scalability problem
por: Haider, Hiba A., et al.
Publicado: (2023)

Management of Low-Grade Appendiceal Mucinous Neoplasm with Extensive Peritoneal Spread Diagnosed during Pregnancy: Two Case Reports and Literature Review
por: Baron, Ekaterina, et al.
Publicado: (2020)

Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD
por: Inoue, Hideki, et al.
Publicado: (2020)

Online Group Course for Parents With Mental Illness: Development and Pilot Study
por: van der Zanden, Rianne AP, et al.
Publicado: (2010)

Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis
por: Jirak, Peter, et al.
Publicado: (2022)

Impact of Dexamethasone and Inhaled Nitric Oxide on Severe Acute Kidney Injury in Critically Ill Patients with COVID-19
por: Bobot, Mickaël, et al.
Publicado: (2022)

Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study
por: Raymond, Matthieu, et al.
Publicado: (2022)

Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2023)

Diffuse Ectopic Deciduosis Imitating Peritoneal Carcinomatosis with Acute Abdomen Presentation: A Case Report and Literature Review
por: Sorokin, Pavel, et al.
Publicado: (2020)

Development of the Interdisciplinary and Interprofessional Course Concept “Advanced Critical Illness Life Support”
por: Michael, Mark, et al.
Publicado: (2022)

Short courses
Publicado: (1989)

Short courses
Publicado: (1989)

Correction: Evaluation of the use of methylprednisolone and dexamethasone in asthma critically ill patients with COVID-19: a multicenter cohort study
por: Al Sulaiman, Khalid, et al.
Publicado: (2023)

Sex Differences in Short- and Long-Term Survival Among Critically Ill Patients with Sepsis
por: Lin, Shan, et al.
Publicado: (2021)

Development of a short course on management of critically ill patients with acute respiratory infection and impact on clinician knowledge in resource‐limited intensive care units
por: Diaz, Janet V., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5o41hug0ebonv33q51omcoouj8